Financial Toxicity in U.S. Cancer Care

This document explains why 42 percent of U.S. cancer patients lose all their wealth within two years of diagnosis and quantifies the average amount of money lost. The analysis draws on peer‑reviewed health‑economic research, including the American Journal of Medicine’s landmark study on cancer‑related financial toxicity.

Wealth Loss Among Cancer Patients

Research shows that 42.4 percent of cancer patients deplete their entire life savings within two years of diagnosis. This phenomenon is known as financial toxicity, a term used to describe the severe economic burden imposed by cancer treatment, supportive care, and associated nonmedical costs.

The average amount of wealth lost within two years is $92,098. This figure represents the typical depletion of savings, retirement accounts, and liquid assets among middle‑income households facing cancer treatment.

Is This Due to Lack of Insurance?

The loss of wealth is not primarily due to lack of insurance. In fact, most patients in the study were insured through employer plans, Medicare, or Medicaid. The problem is underinsurance, meaning that insurance coverage is insufficient to protect patients from catastrophic financial harm.

Insurance fails to prevent wealth loss for several reasons. High deductibles and copayments for chemotherapy, radiation, surgery, imaging, and supportive medications create substantial out‑of‑pocket obligations. Nonmedical costs such as travel, lodging, and caregiver time are not covered by insurance. Additionally, many patients experience significant income loss due to reduced work capacity or job loss during treatment.

Thus, the financial devastation arises from the structure of U.S. insurance systems rather than from lack of coverage.

Drivers of Financial Collapse

The following factors contribute to the rapid depletion of wealth among cancer patients:

Driver	Description	Impact
High Out‑of‑Pocket Costs	Deductibles, copayments, coinsurance for chemotherapy, radiation, surgery, imaging, and medications	Large immediate financial burden even with insurance
Nonmedical Expenses	Travel, lodging near treatment centers, caregiver time, household support	Not covered by insurance; adds thousands in additional costs
Income Loss	Reduced work capacity or job loss during treatment	Sharp decline in household earnings
High Drug Prices	Modern oncology drugs often cost $100,000+ per year	Insurance cost‑sharing remains substantial

Summary

Forty‑two percent of cancer patients lose all their wealth within two years, with an average loss of $92,098. This outcome is driven by underinsurance, high treatment costs, nonmedical expenses, and income loss. Insurance coverage does not adequately protect patients from the economic consequences of cancer treatment.